Trial Profile
Effect of Lactobacillus reuteri DSM 17938 in Infants with Functional Chronic Constipation and the Change of Intestinal Microbiome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2022
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary) ; Magnesium oxide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 20 Oct 2022 Status changed from active, no longer recruiting to completed.
- 07 Sep 2018 New trial record